Linklaters' Schmidt on Pfizer-Wyeth review
Posted on November 6, 2009 at 3:50 PM
Filed under: Acquisitions
Tagged: Jeffrey Schmidt , Linklaters , Pfizer Inc. , Wyeth
Filed under: Acquisitions
Tagged: Jeffrey Schmidt , Linklaters , Pfizer Inc. , Wyeth
The approval by U.S. antitrust regulators of Pfizer Inc.'s (NYSE:PFE) acquisition of Wyeth is an outlier of how merger reviews will be conducted under the Obama administration. That's according to Jeffrey Schmidt, a partner with Linklaters and a former director of the Federal Trade Commission's office of competition under President... Continue reading























And the winners are...



